Merck
CN
Search Within
文件类型

214-188-9

应用筛选条件
关键词:'214-188-9'
显示 1-30 共 45 条结果 关于 "214-188-9" 范围 技术文档
Data Sheet - C1653 - Lot 121K8804
15000 20000 m/z Abundance 42 59 70 81 94 115 124 141 152 162 175 188 214 229 242 256 282 299 Hewlett-Packard 5890 Series II
Data Sheet - C1653 - Lot 43K8806
8000 9000 m/z Abundance 42 59 77 91 103 115 128 152 162 181 188 197 214 229 242 256 282 299 Mattson
Acrylamido Buffers
284 218 - - - - - 636 132 157 19 195 -
XP725 Antibody Number-Lot Number 071M4826
255 256 277 278 279 280 3.5 209 210 211 212 233 234 235 236 257 258 259 260 281 282 283 284 3.6 213 214 215 216 237 238 239 240 261 262 263 264 285 286 287 288 4.1 289 290
Data Sheet - P3244
(1991). 3. Soares, A.D., et.al., Arch. Biochem. Biophys. 387, 188-196, (2001). 4. Vermehren, C., et al., Int. J. Pharm., 214, 93- 98, (2001).
Exploring Akt/mTOR Signaling Using the MILLIPLEX®MAP Akt/mTOR 11-plex Panel
51 163 39 86 50 Pancreas 188 87 35 ND 37 140 51 220 50 82 61 Pituitary 2173 5434 2722 ND 269 2212 1752 509 241 370 305 Prostate 1556 5382 2673 ND 233 2309 1771
Product Information - CSAA1
Transduction P y y n/d 213 Map Kinase Phosphatase-1 (MKP-1) M3787 Signal Transduction P y n/d n/d 214 Protein phosphatase 1α P7979 Signal Transduction P y n/d n/d 215 PTEN P7482 Signal Transduction P
PKH Dye Reference Guide
of fresh and cryopreserved human peripheral blood mononuclear cells. J Immunol Methods 1998; 214: 175-186 2. Boutonnat J,Muirhead K, Barbier M, Mousseau M, Ronot X, Seigneurin D: The use
User Guide - SCC310-370
margin to UC SCC358 ht-213-D 36 F Duodenum Normal margin to UC SCC359 ht-214-I 46 M Ileum Normal margin to UC SCC360 ht-214-I-J 46 M Ileum J-pouch Normal margin to UC SCC361 ht-227-D 62 M Duodenum Normal
Antibody Sourcebookル Sixth Edition
, rat PC�72 25 µg €294 Anti-PARP (215-228) Rabbit pAb ELISA, IB, IF human 5127�9 100 µl €��1 Anti-PARP-1 (197-214) Rabbit pAb ELISA, IB, IC, IF, IP human 5127�8 100 µl €�04 Anti-PARP-1 (Ab-1) Rabbit
Inhibitor Sourcebook 3rd Edition
). Specificity test shows ≥ 50% inhibition, in the presence of 10 µM ATP and inhibitor, against 9 of 214 non-PAK human kinases. Shown to effectively suppress both basal and PDGF-induced PAK activation
Calbiochem Biologics 33.2
Med. Chem. 49, 4896 . Visit our website www .merckbio .eu Calbiochem • Biologics 33 .214 K-LISA™ Aurora Kinase Activity Kit Format: 96-well plate Sensitivity: 16 ng for Aurora A; 11 ng
Chrombook (WEB-Version)
Detection UV 214 nm Sample 1 µL BSA digest (1mg/mL) 0 1 2 3 4 5 6 1 2 3 4 5 [min] www.merck-chemicals.com/analytical-hplc An al yt ic al H
Calbiochem Biologics 30.2
II. Suitable for the dephosphorylation of phosphotyrosine residues in substrate proteins. 20 µg 214 Protein Tyrosine Phosphatase PRL-3, GST-Fusion, Human, Recombinant, E. coli 539807 The catalytic
PureFlex™ and PureFlex™ Plus White Paper
reagent grade water to 100% acetonitrile. Detection was performed using UV detectors at 214 nm and 254 nm. Ion Chromatography (IC) IC was used to identify and quantify small organic
Calbiochem Biologics 32.2
enzyme that will hydrolyze 1.0 nmol of pNPP per minute at 30°C. M.W. 60,300 Cat. No. 535857 20 mg € 214 Ref.: Huynh, H., et al. 2003. J. Immunol. 171, 6661; Qi, Y., et al. 2002. J. Cell Biochem. 86
JULABO Catalog 2011 en
22 III (FL) 3x400/50/22 59 x 76 x 116 195 9 352 790 FP90-SL 0.4-0.7 0.2-0.4 22-26 M16x1 8 / 12 mm 28 x 23 / 22 22 III (FL) 3x400/50/22 59 x 76 x 116 188 9 352
BRAND Katalog EN
182, 184, 188 High-temperature 185 Low-temperature 185 Maximum- 184 Maximum-minimum 188 Precision 184 - 188 Solid-stem 182 - 187 Stirring 182 with standard ground joint 188 without
User Guide Equinox SOP Software 2.1 for Windows XP
203 203 203 204 204 205 205 206 206 207 207 208 208 209 209 210 210 210 211 211 213 213 213 214 214 215 215 216 216 Contenido Capítulo 4. Exportar los procedimientos SOP a la bomba Steritest
Mobius®Chrom 20 System User guide
.................................... 188 Required Supplies .................................................................................................. 188 Set-up ..............................
Brochure: Ascentis® Express Fused-Core® HPLC and UHPLC Columns
/min Sample: 500 - 1000 µg/mL in 95:5, buffer: acetonitrile Injection: 1 µL Detector: UV, 214 nm Min 1.0 2.0 3.0 4.0 5.0 1. Acesulfame 2. Caffeine 3. Benzoic acid 4. Aspartame1 2 3
Biologics 31.1
myopathy, and hyperCKemia. References: Williams, T.M., and Lisanti, M.P. 2004. Genome Biol. 5, 214; Hnasko, R., and Lisanti, M.P. 2003. Mol. Interv. 3, 445; Razani B, et al. 2002. Mol. Cell Biol. 22
Calbiochem Biologics 31.1
myopathy, and hyperCKemia. References: Williams, T.M., and Lisanti, M.P. 2004. Genome Biol. 5, 214; Hnasko, R., and Lisanti, M.P. 2003. Mol. Interv. 3, 445; Razani B, et al. 2002. Mol. Cell Biol. 22
XP725 Antibody List Lot 129K4831
Cathepsin L C2970 1514 CTSL1 M NP_001903.1 y y y 213 DAPK D2178 1611 DAP M NP_004385.1 y n/d n/d 214 phospho-DAPK (pSer308) D4941 1612 DAPK1 M NP_004929.2 y n/d n/d 765 Zip
XP725 Antibody List Lot 129K4830
Cathepsin L C2970 1514 CTSL1 M NP_001903.1 y y y 213 DAPK D2178 1611 DAP M NP_004385.1 y n/d n/d 214 phospho-DAPK (pSer308) D4941 1612 DAPK1 M NP_004929.2 y n/d n/d 765 Zip
XP725 Antibody List Lot 089K4791
Cathepsin L C2970 1514 CTSL1 M NP_001903.1 y y y 213 DAPK D2178 1611 DAP M NP_004385.1 y n/d n/d 214 phospho-DAPK (pSer308) D4941 1612 DAPK1 M NP_004929.2 y n/d n/d 765 Zip
3D BIOPRINTING: Printing a Brighter Future
Tissue Eng. Regen. Med. 2015, 9 (11), 1286–1297. (28) Izadifar, Z.; Chang, T.; Kulyk, W.; Chen, X.; Eames, B. Tissue Eng. Part C Methods 2016, 22 (3), 173–188. (29) Distler, T.; Solisito, A.; Schneidereit
3D BIOPRINTING: Printing a Brighter Future
Tissue Eng. Regen. Med. 2015, 9 (11), 1286–1297. (28) Izadifar, Z.; Chang, T.; Kulyk, W.; Chen, X.; Eames, B. Tissue Eng. Part C Methods 2016, 22 (3), 173–188. (29) Distler, T.; Solisito, A.; Schneidereit
Acta Volume 49 Number 3
www.ncbi.nlm.nih.gov/ books/NBK55878/ (accessed Sep 19, 2016). (8) Schoental, R. Nature 1960, 188, 420. (9) Lewis, C. E. J. Occup. Med. 1964, 6, 91. (10) Arndt, F. In Organic Syntheses; Wiley: New York
A list of advantages for the global market
100887 Ethyl 4-hydroxybenzoate, suitable for use as excipient EMPROVE® exp Ph Eur, BP, JP, NF, E 214 EXP • • • • • 100864 Ethyl acetate, suitable for use as excipient EMPROVE® exp
1/2